These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36754227)

  • 1. Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors.
    Azzaz F; Hilaire D; Fantini J
    Chem Biol Interact; 2023 Mar; 373():110384. PubMed ID: 36754227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1.
    Mahrhold S; Bergström T; Stern D; Dorner BG; Åstot C; Rummel A
    Biochem J; 2016 Sep; 473(17):2645-54. PubMed ID: 27313224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A:
    Azzaz F; Hilaire D; Fantini J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin.
    Weisemann J; Stern D; Mahrhold S; Dorner BG; Rummel A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding.
    Gustafsson R; Zhang S; Masuyer G; Dong M; Stenmark P
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29649119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.
    Dong M; Liu H; Tepp WH; Johnson EA; Janz R; Chapman ER
    Mol Biol Cell; 2008 Dec; 19(12):5226-37. PubMed ID: 18815274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding peptide competitive inhibition of botulinum neurotoxin A binding to SV2 protein via molecular dynamics simulations.
    Chang S; He HQ; Shen L; Wan H
    Biopolymers; 2015 Oct; 103(10):597-608. PubMed ID: 26178648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C.
    Benoit RM; Schärer MA; Wieser MM; Li X; Frey D; Kammerer RA
    Sci Rep; 2017 Mar; 7():43588. PubMed ID: 28252640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the interaction of botulinum neurotoxin a with its neuronal receptor SV2C.
    Li X; Brunner C; Wu Y; Leka O; Schneider G; Kammerer RA
    Toxicon; 2020 Feb; 175():36-43. PubMed ID: 31783045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
    Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
    J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A
    Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2.
    Liu Z; Lee PG; Krez N; Lam KH; Liu H; Przykopanski A; Chen P; Yao G; Zhang S; Tremblay JM; Perry K; Shoemaker CB; Rummel A; Dong M; Jin R
    Nat Commun; 2023 Apr; 14(1):2338. PubMed ID: 37095076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.
    Rummel A
    Curr Top Microbiol Immunol; 2017; 406():1-37. PubMed ID: 27921176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.
    Benoit RM; Frey D; Hilbert M; Kevenaar JT; Wieser MM; Stirnimann CU; McMillan D; Ceska T; Lebon F; Jaussi R; Steinmetz MO; Schertler GF; Hoogenraad CC; Capitani G; Kammerer RA
    Nature; 2014 Jan; 505(7481):108-11. PubMed ID: 24240280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
    Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
    Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A.
    Yao G; Zhang S; Mahrhold S; Lam KH; Stern D; Bagramyan K; Perry K; Kalkum M; Rummel A; Dong M; Jin R
    Nat Struct Mol Biol; 2016 Jul; 23(7):656-62. PubMed ID: 27294781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.
    Kroken AR; Karalewitz AP; Fu Z; Kim JJ; Barbieri JT
    J Biol Chem; 2011 Jul; 286(30):26828-37. PubMed ID: 21632541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain.
    Tepp WH; Bradshaw M; Gardner AP; Kaufman RL; Barbieri JT; Pellett S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors.
    Peng L; Tepp WH; Johnson EA; Dong M
    PLoS Pathog; 2011 Mar; 7(3):e1002008. PubMed ID: 21483489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
    Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR
    FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.